Merkava tank exports rise 10%

The Manufacturers Association of Israel said Tuesday it expects exports of the Merkava tank to grow 10% to $310 million by year end.

By AVI KRAWITZ
November 15, 2006 08:13

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Manufacturers Association of Israel said Tuesday it expects exports of the Merkava tank to grow 10% to $310 million by year end. That growth should continue next year with exports of the armored vehicle reaching $370m. in 2007, the association said. Local sales of the tank also are expected to soar as indications from the Israel Defense Force show it plans to replace 40% of its old tanks with the Merkava 4 over the next 20 years. The IDF intends to upgrade 2% to 3% of its total tank force in the coming year, the association said.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS